reports
- MarketLine Department
ShanPar Industries Pvt Ltd - Strategy, SWOT and Corporate Finance Repo...
Summary ShanPar Industries Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights ShanPar Industries Pvt Ltd (Shanpar) is a manufacturer of specialty ingredients. The company primarily offers wide range of nutraceuticals, feed additives, mineral fortifiers, and s...
AARTI INDUSTRIES sees an upgrade to Positive due to a better fundament...
The general evaluation of AARTI INDUSTRIES (IN), a company active in the Speciality Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date December 31, 2021, the closing price was INR 1,0...
Aarti Industries Limited: 1 director sold
A director at Aarti Industries Limited sold 51,764 shares at 1,060.479INR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
- Nitin Agarwal
Aarti Industries' Q3FY20 results (Outperformer) - Stable performance d...
Q3FY20 results Aarti Industries’s (AIL) revenues declined by 3.9% to Rs12.18bn (above est: Rs11.7bn); Notably, Aarti had demerged its Home and Personal care segment in July, hence revenue growth to that extent is not comparable. Increase in crude linked RM prices led to higher realisations as AIL adopts a cost plus model. However temporary nitric acid shortage and macro challenges continued to impact volumes. Speciality chemicals (86% of revenues) grew by 2.8%yoy, while the Pharma segment (1...
- Nitin Agarwal
Aarti Industries' Q1FY20 results (Outperformer) - Good quarter; cautio...
Q1FY20 results Aarti Industries (AIL) reported flattish revenue growth to Rs10.86bn; notably, Aarti had demerged its HPC segment in July, hence revenue growth to that extent is not comparable). Adjusting for the demerger, revenue growth was 8.8% yoy led by 5.5%yoy in speciality chemicals (82% of revenues), while the Pharma segment (18% of revenues) grew by 28%. In constant RM prices speciality chemicals revenues grew by 9.4% Gross margins improved by 760bps to 46.4% (est:41.7%) largely led ...
- Nitin Agarwal
Management Speak: Aarti Industries (Outperformer) - Long-term prospect...
Presented are core arguments from our meeting with Aarti Industries (AIL), in which management has highlighted strong growth prospects. Healthy revenue but conservative PAT guidance: Post strong 31.7% revenue and 45% PAT growth in FY19, AIL’s management has guided healthy 15-20% revenue growth in FY20E, supported by rising proportion of downstream value-added products. However, management guided conservative PAT growth of 12-15% for FY20E, owing to higher overhead expenses associated with th...
- Nitin Agarwal
Aarti Industries' Q4FY19 results (Outperformer) - Strong performance c...
Q4FY19 results Aarti Industries (AIL) reported revenue growth of 17.7% yoy to Rs12.1bn (est: Rs13bn) largely led by improvement in product mix and realisations. Volume growth for speciality chemicals was 3% Revenues from the speciality chemical segment (76% of revenues) grew by 17%yoy, while pharma segment (17% of revenues) and HPC segment grew by 22% and 9% respectively. Gross margins improved by 180bps to 42.8% (est:41.7%) led by improvement in product mix Lower operating expenditure le...
- Nitin Agarwal
Event update: Aarti Industries (Outperformer) - Wins its 3rd big mult...
Event AIL has entered into a US$125m (Rs9bn) multi-year contract with a Global chemical conglomerate for supply of high value speciality chemical Intermediate Key highlights The contract entails supply of high value specialty chemical intermediate for 10 years starting Q4FY21E; This end-use product is one of the major growth initiatives for the customer AIL will set up a dedicated capacity for $15m towards this supply; this product isn’t part of AIL’s current product portfolio AIL has ...
- Nitin Agarwal
Aarti Industries' Q3FY19 results (Outperformer) - Robust performance
Q3FY19 results Aarti Industries (AIL) reported revenue growth of 28% yoy to Rs12.7bn (above our est: Rs12bn) largely led by improvement in product mix and realisations. Volume growth in Q3FY19 was ~4% Revenues from the speciality chemical segment (80% of revenues) grew by 31%yoy, while the Pharma segment (13% of revenues) and HPC segment grew by 23% and 8% respectively. Gross margins declined by 60bps to 41.1% (est:41.3%) on higher crude-linked raw material costs. Lower staff costs and op...
- Nitin Agarwal
Aarti Industries' Q2FY19 results (Outperformer) - Robust all-round per...
Q2FY19 results Aarti Industries (AIL) reported revenue growth of 46.4% yoy to Rs12.9bn (above our est: Rs11.09bn) led by 10% volume growth in the speciality chemical volumes coupled with improvement in product mix and crude price impact Revenues from the speciality chemical segment (80% of revenues) grew by 50.4%yoy, while the Pharma segment (15% of revenues) and HPC segment grew by 40.5% and 13.5% respectively. Gross margins declined by 230bps to 38.9% (est:39%) on higher crude-linked raw ...
- Nitin Agarwal
Aarti Industries' Q2FY19 results (Outperformer) - Robust all-round per...
Q2FY19 results Aarti Industries (AIL) reported revenue growth of 46.4% yoy to Rs12.9bn (above our est: Rs11.09bn) led by 10% volume growth in the speciality chemical volumes coupled with improvement in product mix and crude price impact Revenues from the speciality chemical segment (80% of revenues) grew by 50.4%yoy, while the Pharma segment (15% of revenues) and HPC segment grew by 40.5% and 13.5% respectively. Gross margins declined by 230bps to 38.9% (est:39%) on higher crude-linked raw ...
- Nitin Agarwal
Initiating coverage: Aarti Industries (Outperformer) - Entering into a...
Aarti Industries Limited (AIL) is a leading player in benzene-based intermediate products, and an integral part of value chain for several global chemical majors. AIL’s backward/forward-integrated and diversified business model, which involves the supply of ~125 products to 700-800 customers across geographies, underpins its competitiveness. Despite significant forex and crude volatility, AIL posted 15%/20% EBITDA/PAT CAGR over FY14-18 with 21.6% RoE in FY18, which reflects its robust business m...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.